Exelixis
EXEL
#1827
Rank
ยฃ8.66 B
Marketcap
ยฃ32.32
Share price
-1.20%
Change (1 day)
10.11%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2024: ยฃ0.50 Billion

According to Exelixis's latest financial reports the company's current earnings are ยฃ2.28 Billion. In 2024 the company made an earning of ยฃ0.50 Billion, an increase over its 2023 earnings that were of ยฃ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2024

Annual earnings

Year Earnings Change
2024ยฃ0.50 B164.69%
2023ยฃ0.19 B9.89%
2022ยฃ0.17 B-20.33%
2021ยฃ0.21 B124.82%
2020ยฃ96.91 M-67.14%
2019ยฃ0.29 B-11.94%
2018ยฃ0.33 B185.09%
2017ยฃ0.11 B-325.82%
2016-ยฃ52.02 Million-58.12%
2015-ยฃ0.13 Billion-37.61%
2014-ยฃ0.2 Billion9.75%
2013-ยฃ0.19 Billion65.96%
2012-ยฃ0.11 Billion-291.63%
2011ยฃ57.03 M-195.59%
2010-ยฃ59.67 Million-42.17%
2009-ยฃ0.11 Billion-18.98%
2008-ยฃ0.13 Billion-6.99%
2007-ยฃ0.14 Billion46.3%
2006-ยฃ93.59 Million33.25%
2005-ยฃ70.24 Million-30.92%
2004-ยฃ0.11 Billion44.29%
2003-ยฃ70.47 Million12.86%
2002-ยฃ62.44 Million22.79%
2001-ยฃ50.85 Million60.14%
2000-ยฃ31.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ23.99 B 3,609.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ8.77 B 1,257.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.10 B 844.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.74 B 942.07%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ17.10 B 2,544.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ5.95 B 819.85%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
ยฃ6.90 B 967.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-ยฃ24.12 Million-103.73%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-ยฃ21.52 Million-103.33%๐Ÿ‡บ๐Ÿ‡ธ USA